<?xml version="1.0" encoding="UTF-8"?>
<p id="Par56">All three concentrations (100, 200, and 400 mg/mL) of 
 <italic>L. inermis</italic> showed significant activity against all tested bacteria species, which was comparable to the standard drugs. The highest zone of inhibition was recorded by 
 <italic>L. inermis</italic> against all tested species except 
 <italic>K. pneumonia</italic> ATCC700603
 <italic>, P. aeruginosa</italic> isolates and 
 <italic>K. pneumonia</italic> isolates. 
 <italic>L. insermis</italic> showed exceptional activity against 
 <italic>E. coli</italic> isolates
 <italic>, S. aureus</italic> ATCC 25923
 <italic>,</italic> and MRSA ATCC® 43300™, which was comparable to the conventional drug cefoxitin (Table 
 <xref rid="Tab3" ref-type="table">3</xref>). 
</p>
